2019

We are pleased to inform you that our portfolio company BIOTTS was among the winners of the CBF Award competition start-up category in which the most innovative companies from the BioTech sector participated. The competition’s task is to reveal biotechnology companies and people from Central Europe that excel in innovation, through implementation of ambitious research […]

On Tuesday (14th May) during the European Start-Up Days – event accompanying the 11th European Economic Congress in Katowice – prizes were distributed in the Start-Up Challenge competition. 18 start-ups have been selected from the record number of 300 entries to present their innovations. We are proud of Bioceltix, which have won in the category […]

  We encourage you to read the article from Money.pl portal, which presents development plans for our portfolio company – Bioceltix.  The team of scientists led by Łukasz Bzdzion is working on innovative biological drugs used in the treatment of common diseases in animals that use immunomodulatory properties of mesenchymal stem cells (MSC).  Bioceltix is […]

We encourage you to read the Business Pulse article, which presents the achievements of Bioavlee in terms of the current development and sale of products, but also presents company further plans that wants to primarily conquer foreign markets with its solutions. “The Polish market is not yet well-off enough for companies to invest in innovative […]

Nestmedic S.A. will deliver the Pregnabit system to the University Hospital in Helsinki (HUS). The order for the Pregnabit teleCTG devices and the license are the result of a successful pilot project carried out at HUS. The first full implementation on the Finnish market opens a new chapter in the expansion of the Pregnabit system […]